Maternal medication use and neuroblastoma in offspring

Michael N. Cook, Andrew F. Olshan, Harry A. Guess, David A. Savitz, Charles Poole, Julie Blatt, Melissa L. Bondy, Bradley H Pollock

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

The association between a mother's use of specific medications during pregnancy and lactation and neuroblastoma in her offspring was evaluated in a case-control study. Newly diagnosed cases of neuroblastoma (n = 504) in the United States and Canada were identified between 1992 and 1994 at 139 hospitals affiliated with the Pediatric Oncology Group or the Children's Cancer Group clinical trial programs. One age-matched control was sampled from the community of each case by means of random digit dialing. Exposure information was ascertained retrospectively from mothers in a structured telephone interview. Odds ratios were estimated using conditional logistic regression, with adjustment for maternal sociodemographic factors. The results did not support an association between neuroblastoma and maternal exposure to diuretic agents, antiinfective agents, estrogens, progestins, sedatives, anticonvulsant drugs, or drugs that may form N-nitroso derivatives. Mothers of cases were more likely to report using medications containing opioid agonists while they were pregnant or nursing than were mothers of controls (odds ratio = 2.4, 95% confidence interval: 1.3, 4.3). Specifically, more mothers of cases reported using medications containing codeine while pregnant or nursing than did mothers of controls (odds ratio = 3.4, 95% confidence interval: 1.4, 8.4). This preliminary finding may be due to bias, confounding, or chance, and additional studies are needed for confirmation.

Original languageEnglish (US)
Pages (from-to)721-731
Number of pages11
JournalAmerican Journal of Epidemiology
Volume159
Issue number8
DOIs
StatePublished - Apr 15 2004
Externally publishedYes

Fingerprint

Neuroblastoma
Mothers
Odds Ratio
Nursing
Confidence Intervals
Maternal Exposure
Codeine
Progestins
Anti-Infective Agents
Hypnotics and Sedatives
Lactation
Diuretics
Anticonvulsants
Opioid Analgesics
Canada
Case-Control Studies
Estrogens
Logistic Models
Clinical Trials
Interviews

Keywords

  • Case-control studies
  • Child
  • Codeine
  • Neuroblastoma
  • Pregnancy
  • Risk factors

ASJC Scopus subject areas

  • Epidemiology

Cite this

Cook, M. N., Olshan, A. F., Guess, H. A., Savitz, D. A., Poole, C., Blatt, J., ... Pollock, B. H. (2004). Maternal medication use and neuroblastoma in offspring. American Journal of Epidemiology, 159(8), 721-731. https://doi.org/10.1093/aje/kwh108

Maternal medication use and neuroblastoma in offspring. / Cook, Michael N.; Olshan, Andrew F.; Guess, Harry A.; Savitz, David A.; Poole, Charles; Blatt, Julie; Bondy, Melissa L.; Pollock, Bradley H.

In: American Journal of Epidemiology, Vol. 159, No. 8, 15.04.2004, p. 721-731.

Research output: Contribution to journalArticle

Cook, MN, Olshan, AF, Guess, HA, Savitz, DA, Poole, C, Blatt, J, Bondy, ML & Pollock, BH 2004, 'Maternal medication use and neuroblastoma in offspring', American Journal of Epidemiology, vol. 159, no. 8, pp. 721-731. https://doi.org/10.1093/aje/kwh108
Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J et al. Maternal medication use and neuroblastoma in offspring. American Journal of Epidemiology. 2004 Apr 15;159(8):721-731. https://doi.org/10.1093/aje/kwh108
Cook, Michael N. ; Olshan, Andrew F. ; Guess, Harry A. ; Savitz, David A. ; Poole, Charles ; Blatt, Julie ; Bondy, Melissa L. ; Pollock, Bradley H. / Maternal medication use and neuroblastoma in offspring. In: American Journal of Epidemiology. 2004 ; Vol. 159, No. 8. pp. 721-731.
@article{aec7a0bfccb14b5b89960d9e25ec0952,
title = "Maternal medication use and neuroblastoma in offspring",
abstract = "The association between a mother's use of specific medications during pregnancy and lactation and neuroblastoma in her offspring was evaluated in a case-control study. Newly diagnosed cases of neuroblastoma (n = 504) in the United States and Canada were identified between 1992 and 1994 at 139 hospitals affiliated with the Pediatric Oncology Group or the Children's Cancer Group clinical trial programs. One age-matched control was sampled from the community of each case by means of random digit dialing. Exposure information was ascertained retrospectively from mothers in a structured telephone interview. Odds ratios were estimated using conditional logistic regression, with adjustment for maternal sociodemographic factors. The results did not support an association between neuroblastoma and maternal exposure to diuretic agents, antiinfective agents, estrogens, progestins, sedatives, anticonvulsant drugs, or drugs that may form N-nitroso derivatives. Mothers of cases were more likely to report using medications containing opioid agonists while they were pregnant or nursing than were mothers of controls (odds ratio = 2.4, 95{\%} confidence interval: 1.3, 4.3). Specifically, more mothers of cases reported using medications containing codeine while pregnant or nursing than did mothers of controls (odds ratio = 3.4, 95{\%} confidence interval: 1.4, 8.4). This preliminary finding may be due to bias, confounding, or chance, and additional studies are needed for confirmation.",
keywords = "Case-control studies, Child, Codeine, Neuroblastoma, Pregnancy, Risk factors",
author = "Cook, {Michael N.} and Olshan, {Andrew F.} and Guess, {Harry A.} and Savitz, {David A.} and Charles Poole and Julie Blatt and Bondy, {Melissa L.} and Pollock, {Bradley H}",
year = "2004",
month = "4",
day = "15",
doi = "10.1093/aje/kwh108",
language = "English (US)",
volume = "159",
pages = "721--731",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Maternal medication use and neuroblastoma in offspring

AU - Cook, Michael N.

AU - Olshan, Andrew F.

AU - Guess, Harry A.

AU - Savitz, David A.

AU - Poole, Charles

AU - Blatt, Julie

AU - Bondy, Melissa L.

AU - Pollock, Bradley H

PY - 2004/4/15

Y1 - 2004/4/15

N2 - The association between a mother's use of specific medications during pregnancy and lactation and neuroblastoma in her offspring was evaluated in a case-control study. Newly diagnosed cases of neuroblastoma (n = 504) in the United States and Canada were identified between 1992 and 1994 at 139 hospitals affiliated with the Pediatric Oncology Group or the Children's Cancer Group clinical trial programs. One age-matched control was sampled from the community of each case by means of random digit dialing. Exposure information was ascertained retrospectively from mothers in a structured telephone interview. Odds ratios were estimated using conditional logistic regression, with adjustment for maternal sociodemographic factors. The results did not support an association between neuroblastoma and maternal exposure to diuretic agents, antiinfective agents, estrogens, progestins, sedatives, anticonvulsant drugs, or drugs that may form N-nitroso derivatives. Mothers of cases were more likely to report using medications containing opioid agonists while they were pregnant or nursing than were mothers of controls (odds ratio = 2.4, 95% confidence interval: 1.3, 4.3). Specifically, more mothers of cases reported using medications containing codeine while pregnant or nursing than did mothers of controls (odds ratio = 3.4, 95% confidence interval: 1.4, 8.4). This preliminary finding may be due to bias, confounding, or chance, and additional studies are needed for confirmation.

AB - The association between a mother's use of specific medications during pregnancy and lactation and neuroblastoma in her offspring was evaluated in a case-control study. Newly diagnosed cases of neuroblastoma (n = 504) in the United States and Canada were identified between 1992 and 1994 at 139 hospitals affiliated with the Pediatric Oncology Group or the Children's Cancer Group clinical trial programs. One age-matched control was sampled from the community of each case by means of random digit dialing. Exposure information was ascertained retrospectively from mothers in a structured telephone interview. Odds ratios were estimated using conditional logistic regression, with adjustment for maternal sociodemographic factors. The results did not support an association between neuroblastoma and maternal exposure to diuretic agents, antiinfective agents, estrogens, progestins, sedatives, anticonvulsant drugs, or drugs that may form N-nitroso derivatives. Mothers of cases were more likely to report using medications containing opioid agonists while they were pregnant or nursing than were mothers of controls (odds ratio = 2.4, 95% confidence interval: 1.3, 4.3). Specifically, more mothers of cases reported using medications containing codeine while pregnant or nursing than did mothers of controls (odds ratio = 3.4, 95% confidence interval: 1.4, 8.4). This preliminary finding may be due to bias, confounding, or chance, and additional studies are needed for confirmation.

KW - Case-control studies

KW - Child

KW - Codeine

KW - Neuroblastoma

KW - Pregnancy

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=2342523983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342523983&partnerID=8YFLogxK

U2 - 10.1093/aje/kwh108

DO - 10.1093/aje/kwh108

M3 - Article

C2 - 15051581

AN - SCOPUS:2342523983

VL - 159

SP - 721

EP - 731

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 8

ER -